title: Effectiveness of cholecystokinin-stimulated cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease.
abstract: We retrospectively reviewed the medical records of 107 patients in two community hospitals who had undergone cholecystokinin-stimulated cholescintigraphy with ejection fraction to determine whether this test is reliable in identifying patients whose symptoms will improve following cholecystectomy. Patients with cholelithiasis or incomplete medical records and patients who could not be interviewed were excluded from the study. Forty-two of 58 study patients (72%) had an abnormal ejection fraction (defined as 35% or less); 27 of 42 patients (64%) underwent cholecystectomy. Twenty-six of 27 (96%) reported lessening of or resolution of symptoms following cholecystectomy. Sixty-seven per cent of the surgical specimens from the 27 patients demonstrated chronic cholecystitis. Fifteen of 42 patients (36%) with abnormal ejection fractions did not undergo cholecystectomy; 12 of 15 (80%) also reported lessening or resolution of symptoms. Of the 16 of 58 patients with a normal ejection fraction, 2 underwent cholecystectomy and reported resolution of symptoms. Five of 14 (36%) with normal ejection fractions who did not undergo cholecystectomy reported improvement. In this series, most patients with an abnormal ejection fraction had lessening of symptoms regardless of whether they underwent cholecystectomy.
authors.affiliation: Department of General Surgery, Carolinas Medical Center, Charlotte, North Carolina 28232-2861, USA.
authors.forename: M T
authors.initials: MT
authors.lastname: Mishkind
authors.forename: R F
authors.initials: RF
authors.lastname: Pruitt
authors.forename: D A
authors.initials: DA
authors.lastname: Bambini
authors.forename: A M
authors.initials: AM
authors.lastname: Hakenewerth
authors.forename: M H
authors.initials: MH
authors.lastname: Thomason
authors.forename: J H
authors.initials: JH
authors.lastname: Zuger
authors.forename: T
authors.initials: T
authors.lastname: Novick
mesh_terms: D000328:Adult; D000814:Aniline Compounds; D016022:Case-Control Studies; D002763:Cholecystectomy; D002764:Cholecystitis / Q000000981:diagnostic imaging* / Q000601:surgery*; D002908:Chronic Disease; D005260:Female; D005704:Gallbladder / Q000000981:diagnostic imaging*; D016473:Gallbladder Emptying; D005998:Glycine; D006801:Humans; D007098:Imino Acids; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015609:Organotechnetium Compounds; D011237:Predictive Value of Tests; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals; D012189:Retrospective Studies; D012844:Sincalide
chemical_list: D000814:Aniline Compounds; D007098:Imino Acids; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals; C034837:technetium Tc 99m mebrofenin; D012844:Sincalide; D005998:Glycine